Nextron, a global leader in medical-grade interconnect technologies, today announced the expansion of its specialized connectivity platforms designed for the rapidly evolving field of advanced therapeutic and diagnostic systems. For over 20 years, Nextron has been a key supplier to major multinational corporations and renowned manufacturers of cardiac catheters and minimally invasive medical devices across America, Europe, and Asia.

As the medical industry shifts toward more complex therapeutic platforms, systems such as Pulsed Field Ablation (PFA) and Intravascular Lithotripsy (IVL) are demanding higher electrical and mechanical performance from interconnect architectures. These systems rely on high-density mapping and precise energy delivery while maintaining mechanical durability in compact or disposable formats.

"The clinical effectiveness of modern PFA and IVL systems depends heavily on the stability of high-voltage energy transmission and the fidelity of pulse delivery," according to Nextron’s technical manager. To meet these demands, Nextron’s high-voltage solutions are validated under EIA-364-20 and IEC 60664-4 standards to ensure electrical insulation performance and voltage withstand capability.

To further clinical safety, Nextron’s designs incorporate touch-safe protection features in compliance with IEC 60529 and EN IEC 60335. These reinforced insulation structures and extended creepage distance designs preserve the waveform integrity essential for cardiac ablation while reducing electrical risks in high-energy environments.

For diagnostic applications, Nextron’s high pin-count interconnect technologies support dense electrode arrays and real-time data channels. These solutions offer low-noise signal transmission and reliable electrical isolation, ensuring they are compatible with the specific mechanical requirements of advanced catheter shafts.

In response to the growth of single-use endoscopes and disposable visualization devices, Nextron provides interconnect platforms with IP50 and IP67 ingress protection ratings. These modular, lightweight designs offer flexible pin configurations, allowing for the integration of mixed high-voltage and low-voltage signals within a single interface to accommodate diverse clinical use scenarios.

Nextron operates under ISO 13485 certification and aligns its processes with FDA medical device expectations. This commitment ensures rigorous risk management, traceability, and manufacturing consistency for global medical device manufacturers.

Nextron will exhibit at MD&M West 2026 in Anaheim (February 3–5, Anaheim Convention Center). Attendees can experience hands‑on demos of the Interconnect Solutions at the Nextron booth 3358. To schedule a meeting at MD&M West, please use the Contact Us form on Nextron’s website www.nextrongroup.com/contact